Clinical Trial Update: Administration of High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid Tumors [NA]

View source ↗

Summary

Clinical trial update on administering high-dose thiotepa and melphalan with autologous hematopoietic stem cell transplant in children and adolescents with soli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Tumors
• Tumors

Drugs mentioned

• Melphalan (Melphalan)
• THIOTEPA (THIOTEPA)

Snippet

Sponsor: Rabin Medical Center | Conditions: Central Nervous System Tumors, Tumors | NA | Status: UNKNOWN